Novadaq Technologies Inc.  

(Public, TSE:NDQ)   Watch this stock  
Find more results for NDQ
13.48
-0.22 (-1.61%)
May 3 - Close
TSE data delayed by 15 mins - Disclaimer
Currency in CAD
Range 13.32 - 13.58
52 week 11.79 - 20.40
Open 13.51
Vol / Avg. 3,778.00/1,275.00
Mkt cap 737.51M
P/E     -
Div/yield     -
EPS -0.67
Shares 56.26M
Beta 0.68
Inst. own     -
Jul 26, 2016
Q2 2016 Novadaq Technologies Inc Earnings Release (Estimated) - 4:00PM EDT - Add to calendar
May 24, 2016
Novadaq Technologies Inc at UBS Global Healthcare Conference - 10:30AM EDT - Add to calendar
May 12, 2016
Novadaq Technologies Inc Annual Shareholders Meeting (Estimated) - 9:30AM EDT - Add to calendar
May 5, 2016
Novadaq Technologies Inc at Deutsche Bank Health Care Conference - 1:30PM EDT - Add to calendar
Apr 27, 2016
Q1 2016 Novadaq Technologies Inc Earnings Call
Apr 27, 2016
Q1 2016 Novadaq Technologies Inc Earnings Release
Apr 12, 2016
Novadaq Technologies Inc at Needham Healthcare Conference - Webcast
Mar 23, 2016
Novadaq Technologies Inc at Morgan Stanley Healthcare Corporate Access Day
Mar 16, 2016
Novadaq Technologies Inc at Barclays Global Healthcare Conference - Webcast
Feb 23, 2016
Novadaq Technologies Inc at RBC Capital Markets Healthcare Conference
  

Key stats and ratios

Q1 (Mar '16) 2015
Net profit margin -39.38% -48.31%
Operating margin -47.22% -56.47%
EBITD margin - -45.74%
Return on average assets -16.33% -16.54%
Return on average equity -18.97% -20.19%
Employees 56 -
CDP Score - -

Address

5090 Explorer Dr Suite 202
MISSISSAUGA, ON L4W 4T9
Canada
+1-905-6293822 (Phone)
+1-905-6290282 (Fax)

Website links

Description

Novadaq Technologies Inc. is a medical device company. The Company primarily develops, manufactures and markets real-time fluorescence imaging products that are designed for use by surgeons in the operating room and other clinical settings where open and minimally invasive surgery or interventional procedures are performed. The Company's segment is medical devices. The Company's SPY fluorescence imaging technology platform (SPY Fluorescence Imaging) provides clinically relevant anatomic and physiologic images of blood flow in vessels and micro-vessels during a range of surgical and outpatient procedures performed in the operating room or clinic. The Company's products include SPY, SPY Elite, LUNA and PINPOINT Imaging Systems, SPY Analysis Toolkit, DermACELL and SPY-Q Case Manager. DermACELL is an Acellular Dermal Matrix (ADM) that is used in breast reconstruction surgeries, as well as in the treatment of diabetic foot and venous stasis ulcers, and chronic non-healing wounds.

Officers and directors

Arun Menawat Ph.D. President, Chief Executive Officer, Director
Roger Deck Chief Financial Officer
Anthony F. Griffiths Independent Non-Executive Chairman of the Board
Patrice E. Merrin Director
Age: 66
Robert S. White Director
Age: 54
Aaron Davidson Independent Director
Age: 46
Harold O. Koch Jr. Independent Director
Age: 59